Immobilized DMAP Derivatives
afford 7a (0.64 g, 2.12 mmol, 60%) as a pale-yellow oil together
with unprotected starting material 6 (0.30 g, 1.38 mmol, 39%). H
NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 5.5 Hz, 1 H, 3-H), 7.70
4.58 mmol, 50%) as a pale-yellow oil together with unprotected
starting material 6 (0.90 g, 3.89 mmol, 43%). 1H NMR (300 MHz,
CDCl3): δ = 7.78 (d, J = 5.5 Hz, 1 H, 3-H), 7.72 (s, 1 H, 1-H), 6.38
1
(s, 1 H, 1-H), 6.37 (d, J = 5.5 Hz, 1 H, 4-H), 3.54–3.29 (m, 3 H, (d, J = 5.5 Hz, 1 H, 4-H), 3.48 (m, 3 H, NCH2CH3, 5a-H), 3.25
NCH2CH3, 5a-H), 3.22 [m, 2 H, NCH2(C5H11)], 3.04 (m, 1 H, 9a- (m, 3 H, NCH2CH2CH2CϵCSiMe3, 9a-H), 2.30 (t, J = 6.8 Hz, 2
H), 1.86 (m, 2 H), 1.59 (m, 6 H), 1.33 (m, 8 H), 1.16 (t, J = 7.1 Hz,
H, NCH2CH2CH2CϵCSiMe3), 1.82 (m, 4 H), 1.59 (app. d, 4 H),
3 H, NCH2CH3), 0.90 [m, 3 H, N(C5H10)CH3] ppm. 13C NMR 1.40 (m, 2 H), 1.26 (t, J = 7.1 Hz, 3 H, CH3), 0.18 [s, 9 H, Si-
(75 MHz, CDCl3): δ = 140.5, 140.1, 132.0, 130.9, 104.5, 55.4, 54.5,
(CH3)3] ppm. 13C NMR (75 MHz, CDCl3): δ = 140.7, 140.3, 131.9,
47.2, 41.1, 31.7, 28.0, 27.0, 26.9, 25.5, 22.7, 22.3, 22.2, 14.0,
130.6, 106.4, 104.6, 85.4, 55.2, 54.9, 45.9, 41.1, 28.0, 26.8, 24.2,
11.5 ppm. IR (film): ν = 2928, 2855, 1580, 1514, 1354, 1266,
22.3, 22.2, 17.4, 11.5, 0.14 ppm. IR (film): ν = 2935, 2857, 2173,
˜
˜
1074 cm–1. HRMS (ESI+): calcd. for [C19H31N3 + H]+ 302.2591; 1580, 1515, 1355, 1248 cm–1. HRMS (ESI+): calcd. for [C21H33N3Si
found 302.2590.
+ H]+ 356.2517; found 356.2514.
5-Ethyl-10-(prop-2-ynyl)-5,5a,6,7,8,9,9a,10-octahydropyrido[3,4-b]-
quinoxaline (7b): Compound 6 (1.76 g, 7.61 mmol, 1.0 equiv.) was
dissolved in anhydrous THF (40 mL), and butyllithium (2.5 m in
hexanes, 3.35 mL, 8.37 mmol, 1.1 equiv.) was added dropwise to
this solution through a rubber septum at –78 °C. After 15 min, pro-
pargyl bromide (80 wt.-% in toluene, 1.0 mL, 9.13 mmol,
1.2 equiv.) was added, and the reaction mixture was warmed to
room temperature overnight. The reaction was quenched by adding
EtOH (3 mL), and the solvent was subsequently removed under
reduced pressure. The raw material was taken up in MeOH
(20 mL), and concentrated HCl (0.70 mL, 1.1 equiv.) was added
dropwise to this solution at 0 °C. The reaction mixture was stirred
at this temperature for 5 min, then the solvent was removed under
reduced pressure and the crude material was taken up in CH2Cl2
(40 mL) and saturated K2CO3 (20 mL). The aqueous layer was
washed with CH2Cl2 (10 mL), and the combined organic layers
were dried with Na2SO4, filtered, and concentrated under reduced
pressure to yield an oil, which was purified by column chromatog-
raphy on silica gel (EtOAc/NEt3/MeOH, 20:2:1) to afford 7b
(1.58 g, 6.19 mmol, 80%) as a pale-yellow solid; m.p. 162–164 °C.
1H NMR (300 MHz, CDCl3): δ = 7.85 (m, 2 H, 1-H, 3-H), 6.36
(d, J = 5.5 Hz, 1 H, 4-H), 4.17 (dd, J = 18.3, 2.3 Hz, 1 H,
NCH2CϵCH), 3.92 (dd, J = 18.3, 2.3 Hz, 1 H, NCH2CϵCH),
3.52–3.13 (m, 4 H, NCH2CH3, 5a-H, 9a-H), 2.20 (s, 1 H,
NCH2CϵCH), 2.01 (m, 1 H), 1.85–1.57 (m, 4 H), 1.54–1.23 (m, 3
H), 1.17 (t, J = 7.1 Hz, 3 H, CH3) ppm. 13C NMR (75 MHz,
CDCl3): δ = 142.0, 141.0, 133.0, 129.5, 104.0, 78.5, 72.4, 57.6, 52.6,
5-Ethyl-10-(pent-4-ynyl)-5,5a,6,7,8,9,9a,10-octahydropyrido[3,4-b]-
quinoxaline (7c): Compound 7cЈ (1.50 g, 4.22 mmol, 1.0 equiv.) was
dissolved in MeOH (15 mL), and K2CO3 (0.87 g, 6.33 mmol,
1.5 equiv.) was added. The reaction mixture was stirred at room
temperature overnight, then the solvent was removed under re-
duced pressure, and the crude material was partitioned between
water (100 mL) and CH2Cl2 (200 mL). The aqueous layer was
washed with CH2Cl2 (50 mL), and the combined organic layers
were dried with Na2SO4, filtered, and concentrated under reduced
pressure to afford the title compound as a greenish oil (1.15 g,
1
4.06 mmol, 96%). H NMR (300 MHz, CDCl3): δ = 7.73 (app. d,
2 H, 3-H, 1-H), 6.37 (d, J = 5.4 Hz, 1 H, 4-H), 3.47 (m, 3 H,
NCH2CH3, 5a-H), 3.22 (m, 3 H, NCH2CH2CH2CϵCH, 9a-H),
2.24 (t, J = 10.9 Hz, 2 H, NCH2CH2CH2CϵCH), 2.00 (s, 1 H,
NCH2CH2CH2CϵCH), 1.83 (m, 4 H), 1.58 (m, 4 H), 1.39 (m, 2 H),
1.15 (t, J = 7.1Hz, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ
= 140.8, 140.3, 131.9, 130.6, 104.6, 83.6, 69.0, 55.2, 54.9, 46.3, 40.9,
28.0, 26.7, 24.4, 22.4, 22.0, 16.0, 11.4 ppm. IR (film): ν = 3289,
˜
2932, 2856, 2116, 1579, 1514, 1355, 1266, 1065 cm–1. HRMS
(ESI+): calcd. for [C18H25N3 + H]+ 284.2121; found 284.2121.
10-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-5-ethyl-5,5a,6,7,
8,9,9a,10-octahydropyrido[3,4-b]quinoxaline (8b): Compound 7b
(0.26 g, 1.0 mmol, 1.0 equiv.) was dissolved in anhydrous THF
(10 mL), and the solution was degassed by purging with N2 for
5 min. Benzyl azide (0.16 g, 1.2 mmol, 1.2 equiv.) was added, fol-
lowed by a catalytic amount of CuBr and N,N-diisopropylethylam-
ine (DIPEA; 0.34 mL, 2.0 mmol, 2.0 equiv.). The reaction mixture
was stirred at room temperature for 2 h, then the solution was par-
titioned between CH2Cl2 (20 mL) and saturated K2CO3 (10 mL).
The aqueous layer was washed with CH2Cl2 (10 mL), and the com-
bined organic layers were dried with Na2SO4, filtered, and concen-
trated under reduced pressure to yield an oil that was purified by
column chromatography on silica gel (EtOAc/NEt3/MeOH, 20:2:1)
42.1, 35.2, 28.0, 27.2, 23.5, 20.9, 11.7 ppm. IR (solid): ν = 3096,
˜
2932, 2095, 1587, 1524, 1440, 1274, 1240, 1184, 1076 cm–1. HRMS
(ESI+): calcd. for [C16H21N3 + H]+ 256.1808; found 256.1806.
5-Ethyl-10-[5-(trimethylsilyl)pent-4-ynyl]-5,5a,6,7,8,9,9a,10-octa-
hydropyrido[3,4-b]quinoxaline (7cЈ, Precursor of 7c): Compound 6
(2.10 g, 9.1 mmol, 1.0 equiv.) was dissolved in anhydrous THF
(40 mL), and butyllithium (2.5 m in hexanes, 4.40 mL, 10.92 mmol,
1.2 equiv.) was added dropwise to this solution through a rubber
septum at –78 °C. The reaction mixture was stirred at –78 °C for
15 min and then warmed to 0 °C in an ice bath. After 15 min, (5-
iodo-1-pentynyl)trimethylsilane (11.4 mmol, 1.25 equiv.) was added
dropwise, and the reaction mixture was warmed to room tempera-
ture overnight. The reaction was quenched by adding EtOH
(5 mL), and the solvent was subsequently removed under reduced
pressure. The raw material was taken up in MeOH (20 mL), and
concentrated HCl (0.85 mL, 1.1 equiv.) was added dropwise to this
solution at 0 °C. The reaction mixture was stirred at this tempera-
ture for 5 min, then the solvent was removed under reduced pres-
sure, and the crude material was taken up in CH2Cl2 (50 mL) and
saturated K2CO3 (20 mL). The aqueous layer was washed with
CH2Cl2 (10 mL), and the combined organic layers were dried with
Na2SO4, filtered, and concentrated under reduced pressure to yield
an oil, which was purified by column chromatography on silica
1
to afford 8b (350 mg, 0.90 mmol, 90%) as a white foam. H NMR
(400 MHz, CDCl3): δ = 7.73 (s, 2 H, 3-H, 1-H), 7.34 (s, 1 H, tri-
azole-H), 7.33–7.22 (m, 2 H), 7.24–7.07 (m, 3 H), 6.32 (d, J =
5.5 Hz, 1 H, 4-H), 5.43 (d, J = 7.5 Hz, 1 H, CH2Ph), 5.39 (d, J =
7.5 Hz, 1 H, CH2Ph), 4.65 (d, J = 16.7 Hz, 1 H, NCH2-triazole),
4.43 (d, J = 16.7 Hz, 1 H, NCH2-triazole), 3.44–3.09 (m, 4 H,
NCH2CH3, 5a-H, 9a-H), 2.08 (s, 1 H), 1.77 (m, 1 H), 1.65–1.41
(m, 4 H), 1.40–1.27 (m, 2 H), 1.11 (t, J = 6.9 Hz, 3 H, CH3) ppm.
13C NMR (75 MHz, CDCl3): δ = 144.6, 141.1, 140.4, 134.8, 131.7,
130.6, 129.0, 128.6, 127.8, 122.2, 104.3, 56.3, 54.0, 53.7, 42.3, 41.7,
27.7, 27.2, 22.9, 21.4, 11.6 ppm. IR (solid): ν = 2931, 2856, 1361,
˜
1267, 1200, 1047 cm–1. HRMS (ESI+): calcd. for [C23H28N6 + H]+
389.2448; found 389.2442.
10-[3-(1-Benzyl-1H-1,2,3-triazol-4-yl)propyl]-5-ethyl-5,5a,6,7,
8,9,9a,10-octahydropyrido[3,4-b]quinoxaline (8c): Compound 7c
(0.38 g, 1.3 mmol, 1.0 equiv.) was dissolved in anhydrous THF
gel (EtOAc/NEt3/MeOH, 20:2:1; Rf = 0.90) to afford 7cЈ (0.90 g, (15 mL), and the solution was degassed by purging with N2 for
Eur. J. Org. Chem. 2011, 1527–1533
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1531